Antares Pharma Inc. (ATRS) develops and markets injector solutions for a variety of self-administered therapies. It rallied sharply off the December 2008 bear market low at 29-cents, reaching an all-time high at $5.58 in July 2012. The subsequent downtrend finally ended at 67-cents in March 2016, giving way to a channeled uptick that remains in force more than 11-months later. This bullish pattern predicts a buying opportunity when the price drops to $2.00 or breaks the channel to the upside.
